Publications by authors named "T Pressler"

Claim this Profile
C
Change in pulmonary pathogens 3 years after elexacaftor/tezacaftor/ivacaftor: an observational study in the Danish cystic fibrosis cohort.
Maria Pals Bendixen, Majbritt Jeppesen, Oihane Irazoki, Camilla Bjørn Jensen, Mikala Wang, Tacjana Pressler

Clin Microbiol Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes of nontuberculous mycobacterial infection in the Danish Cystic Fibrosis Cohort 2012-23.
Christian Leo-Hansen, Bibi U Nielsen, Thomas Bryrup, Majbritt Jeppesen, Mette Kolpen, Tacjana Pressler

J Cyst Fibros· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass, linear growth, and body composition before and after the introduction of elexacaftor/tezacaftor/ivacaftor among children and adults with cystic fibrosis.
Karlen Bader-Larsen, Bibi Uhre Nielsen, Esben Henriksen, Thomas Bryrup, Christian Leo-Hansen, Tacjana Pressler

Clin Nutr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe hepatotoxicity is uncommon following the introduction of Elexacaftor/Tezacaftor/Ivacaftor: A real-world two-years follow-up study of the Danish cystic fibrosis cohort.
Christine Højte, Mette Frahm Olsen, Daniel Faurholt-Jepsen, Marianne Hørby Jørgensen, Tacjana Pressler

J Cyst Fibros· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Improvements of Lung Clearance Index and Ventilation Distribution Efficiency in Children With Cystic Fibrosis After Elexacaftor/Tezacaftor/Ivacaftor Initiation.
Esben Herborg Henriksen, Rikke Mulvad Sandvik, Mette Frahm Olsen, Tacjana Pressler, Thomas Bryrup

Pediatr Pulmonol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis